Kathryn E Lewandowski1, Fei Du2, Xiaoying Fan2, Xi Chen2, Polly Huynh3, Dost Öngür2. 1. McLean Hospital, 115 Mill St., Belmont, MA 02478, United States of America; Harvard Medical School, 25 Shattuck St., Boston, MA 02115, United States of America. Electronic address: klewandowski@mclean.harvard.edu. 2. McLean Hospital, 115 Mill St., Belmont, MA 02478, United States of America; Harvard Medical School, 25 Shattuck St., Boston, MA 02115, United States of America. 3. McLean Hospital, 115 Mill St., Belmont, MA 02478, United States of America.
Abstract
BACKGROUND: White matter (WM) abnormalities are amongst the most commonly described neuroimaging findings in patients with psychotic disorders including schizophrenia (SZ) and bipolar disorder (BD), and may be central to pathophysiology. Few studies have directly compared WM abnormalities in patients with SZ and BD in the first episode of illness, and no studies to date have attempted to separate abnormalities of axon and myelin using complementary MRI techniques. METHODS: We examined WM abnormalities in young adults with SZ (n = 19) or BD (n = 16) within the first year of illness onset, and healthy controls (n = 22) using a combination of diffusion tensor spectroscopy to measure NAA, creatine (Cr), and choline (Cho), and magnetization transfer ratio (MTR). MTR reflects myelin content, NAA diffusion is neuron specific, and Cr and Cho diffusion reflect both neuron and glial signal. RESULTS: We found no differences in MTR or NAA ADC in either patient group compared to controls, but significant elevations of both Cr and Cho diffusion in patients with SZ, and elevations of Cho diffusion in patients with BD. Elevations in Cr and Cho diffusion in the absence of NAA diffusion abnormalities indicate that the aberrant signal arises in glia. CONCLUSIONS: Glial abnormalities were present and detectable by the first episode of psychosis, whereas major abnormalities in axon and myelin were not. Examination of these neurobiological markers early in the course of illness may clarify the neuroprogressive nature of these distinct aspects of WM, and their associations with early clinical phenotypes.
BACKGROUND:White matter (WM) abnormalities are amongst the most commonly described neuroimaging findings in patients with psychotic disorders including schizophrenia (SZ) and bipolar disorder (BD), and may be central to pathophysiology. Few studies have directly compared WM abnormalities in patients with SZ and BD in the first episode of illness, and no studies to date have attempted to separate abnormalities of axon and myelin using complementary MRI techniques. METHODS: We examined WM abnormalities in young adults with SZ (n = 19) or BD (n = 16) within the first year of illness onset, and healthy controls (n = 22) using a combination of diffusion tensor spectroscopy to measure NAA, creatine (Cr), and choline (Cho), and magnetization transfer ratio (MTR). MTR reflects myelin content, NAA diffusion is neuron specific, and Cr and Cho diffusion reflect both neuron and glial signal. RESULTS: We found no differences in MTR or NAA ADC in either patient group compared to controls, but significant elevations of both Cr and Cho diffusion in patients with SZ, and elevations of Cho diffusion in patients with BD. Elevations in Cr and Cho diffusion in the absence of NAA diffusion abnormalities indicate that the aberrant signal arises in glia. CONCLUSIONS:Glial abnormalities were present and detectable by the first episode of psychosis, whereas major abnormalities in axon and myelin were not. Examination of these neurobiological markers early in the course of illness may clarify the neuroprogressive nature of these distinct aspects of WM, and their associations with early clinical phenotypes.
Authors: Luca De Peri; Alessandra Crescini; Giacomo Deste; Paolo Fusar-Poli; Emilio Sacchetti; Antonio Vita Journal: Curr Pharm Des Date: 2012 Impact factor: 3.116
Authors: Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw Journal: Arch Gen Psychiatry Date: 2004-05
Authors: Mark Drakesmith; Anirban Dutt; Leon Fonville; Stanley Zammit; Abraham Reichenberg; C John Evans; Glyn Lewis; Derek K Jones; Anthony S David Journal: JAMA Psychiatry Date: 2016-04 Impact factor: 21.596
Authors: Klaus Schmierer; Francesco Scaravilli; Daniel R Altmann; Gareth J Barker; David H Miller Journal: Ann Neurol Date: 2004-09 Impact factor: 10.422
Authors: Du Lei; Xueling Suo; Kun Qin; Walter H L Pinaya; Yuan Ai; Wenbin Li; Weihong Kuang; Su Lui; Graham J Kemp; John A Sweeney; Qiyong Gong Journal: Transl Psychiatry Date: 2022-05-06 Impact factor: 7.989